Abstract
A variety of new compounds containing two or three biologically active imidazolidine-2,4-dione and thiazolidine-2,4-dione (TZD) cores through two- and three-way optimization of 3 and 4CR by Knoevenagel condensation were synthesized (Method A). In another attempt, two and three Bucherer–Berg modified with 5 and 7CR directed to synthesize larger homologous molecules were used (Method B). The structure of these derivatives was confirmed by FT-IR, 1HNMR, 13CNMR, and Elemental analysis. To evaluate the anticonvulsant activity of these derivatives, all the compounds were considered to be studied through molecular docking for Anticonvulsant Drug Binding (ADB) to the Voltage-Gated Sodium Channel Inner Pore (VGCIP). The in-silico molecular docking study results showed that molecules 5c, 7, 9, and 10 among the synthesized compounds with − 8.31, − 9.23, − 8.91, and − 10.79 kJ mol−1 glide scores respectively, lead to more binding affinity toward the channel and fitting well in the active pocket, thus, they may be considered as good anticonvulsant agents. Also, to evaluate the antibacterial properties of these derivatives, the ligand–protein molecular docking calculation using the active sites of the following bacterial proteins has been performed. Gram-positive bacteria such as B. anthracis (PDB ID: 3TYE) and S. aureus (PDB ID: 3ACX) and gram-negative bacteria E. coli (PDB ID: 1AB4) and P. aeruginosa (PDB ID: 5U39). The most significant overall score has been obtained for S. aureus (PDB ID: 3ACX) bacteria. According to the calculation compound 10 leads to the most efficient antibacterial activity against two Gram-positive bacteria and compounds 4a and 7 with Gram-negative proteins bacterial. The highest binding affinity is related to compound 7 for the Gram-negative P. aeruginosa (PDB ID: 5U39) protein target. The antibacterial properties of these derivatives were also experimentally investigated confirming the results obtained by the ligand–protein molecular docking calculation.
Similar content being viewed by others
Data availability
The data that support the findings of this study are openly available within the article [and/or] its supplementary materials.
References
N.C. Desai, U.P. Pandit, A. Dodiya, Expert Opin. Ther. Pat. 25, 479 (2015)
S. Kaur Manjal, R. Kaur, R. Bhatia, K. Kumar, V. Singh, R. Shankar, R. Kaur, R.K. Rawal, Bioorg. Chem. 75, 406 (2017)
L. Konnert, F. Lamaty, J. Martinez, E. Colacino, Chem. Rev. 117, 13757 (2017)
L. Konnert, B. Reneaud, R.M. De Figueiredo, J.M. Campagne, F. Lamaty, J. Martinez, E. Colacino, J. Org. Chem. 79, 10132 (2014)
V. Asati, D.K. Mahapatra, S.K. Bharti, Eur. J. Med. Chem. 87, 814 (2014)
M. Youssef, M. Sydney White, E.B. Villanueva, I.M. El-Ashmawy, A. Klegeris, Bioorgan. Med. Chem. 18, 2019 (2010)
F. Ghanbari Pirbasti, N.O. Mahmoodi, J. Abbasi Shiran, J. Sulfur Chem. 37, 196 (2016)
A. Elhenawy, A.A.A. Salama, M.M.A. All, A.A. Alomri, H.S. Nassar, Int. J. Pharm. Sci. Rev. Res. 31, 23 (2015)
I. Khodair, P. Bertrand, Tetrahedron 54, 4859 (1998)
N.O. Mahmoodi, Z. Khodaee, Arkivoc 3, 29 (2007)
F. Abdel-Wahab, G.E.A. Awad, F.A. Badria, Eur. J. Med. Chem. 46, 1505 (2011)
N.O. Mahmoodi, Z. Khodaee, Mendeleev Commun. 14, 304 (2004)
M. C. Kandemir, A. Saları, B. Bıçak, and S. K. Gündüz, 3 (2019)
Z. Khodaeea, N.O. Mahmoodi, A. Yahyazadeh, Org. Chem. Res. 3(2), 112 (2017)
H. Kumar, A. Deep, R.K. Marwaha, BMC Chem. 14, 1 (2020)
M.S. Hill, D.J. Liptrot, M.F. Mahon, Angew. Chemie - Int. Ed. 52, 5364 (2013)
L. Vatannavaz, S.J. Sabounchei, A. Sedghi, R. Karamian, S.H.M. Farida, N. Rahmani, Polyhedron 181, 114478 (2020)
Y. Nan Sun, Z. Xuan Yang, F. Zheng Ren, B. Fang, Int. J. Biol. Macromol. 158, 401 (2020)
H. Gao, L. Ding, R. Liu, X. Zheng, X. Xia, F. Wang, J. Qi, W. Tong, Y. Qiu, Int. J. Biol. Macromol. 179, 259 (2021)
K. Dhara, S. Paladhi, G.C. Midya, J. Dash, Org. Biomol. Chem. 9, 3801 (2011)
N. Chadha, M.S. Bahia, M. Kaur, O. Silakari, Bioorgan. Med. Chem. 23, 2953 (2015)
N. Kumar, S. Thomas, R. Rao, N. Maiti, R.J. Kshirsagar, J. Phys. Chem. A 123, 9770 (2019)
Y.C. Chen, S. Da Huang, J.H. Tu, J.S. Yu, A.O. Nurlatifah, W.C. Chiu, Y.H. Su, H.L. Chang, D.A. Putri, H.L. Cheng, Int. J. Biol. Macromol. 146, 202 (2020)
N. Dieltiens, D.D. Claeys, C.V. Stevens, J. Org. Chem. 71, 3863 (2006)
V. Haridas, S. Sadanandan, G. Hundal, C.H. Suresh, Tetrahedron Lett. 53, 5523 (2012)
A.S. Hosseinzadeh, M. Beni, M.Z. Azari, M. Karami, New J. Chem. 40, 8371 (2016)
N. Sepay, S. Mallik, P.C. Saha, A.K. Mallik, New J. Chem. 42, 15270 (2018)
Y. Wang, P.J. Jones, T.W. Batts, V. Landry, M.K. Patel, M.L. Brown, Bioorganic. Med. Chem. 17, 7064 (2009)
Y. Yaari, M.E. Selzer, G. David, Brain Res. 345, 102 (1985)
S. Botros, N.A. Khalil, B.H. Naguib, Y. El-Dash, Eur. J. Med. Chem. 60, 57 (2013)
M. Sitges, L.M. Chiu, R.C. Reed, Neurochem. Res. 41, 758 (2016)
S. Ali, S. Alarifi, S. Kumar, I. Akbar, J. Infect. Public Health 13, 1951 (2020)
Y. Ma, T.T. Ding, Y.Y. Liu, Z.H. Zheng, S.X. Sun, L.S. Zhang, H. Zhang, X.H. Lu, X.C. Cheng, R.L. Wang, Biochem. Biophys. Res. Commun. 19, 40 (2021)
S. Keivanloo, S. Lashkari, M.B. Sepehri, S. Abbaspour, Monatshefte Chemie - Chem Mon. 6, 151 (2020)
N. Trotsko, J. Golus, P. Kazimierczak, A. Paneth, A. Przekora, G. Ginalska, M. Wujec, Bioorg. Chem. 97, 103676 (2020)
S.G. Alegaon, K.R. Alagawadi, Med. Chem. Res. 21, 816 (2012)
L. Zare, N.O. Mahmoodi, A. Yahyazadeh, M. Mamaghani, Synthet. Communi. 41(15), 2323 (2011)
L. Zare, N.O. Mahmoodi, A. Yahyazadeh, M. Mamaghani, J. Heterocycl. Chem. 48, 864 (2011)
N.O. Mahmoodi, S. Emadi, Russ. J. Org. Chem. 40, 377 (2004)
S. Keivanloo, S. Lashkari, M.B. Sepehri, S. Abbaspour, J. Chin. Chem. Soc. 68, 1317 (2021)
M.Y. Yu, S.N. Liu, H. Liu, Q.H. Meng, X.J. Qin, H.Y. Liu, Bioorg. Chem. 117, 105404 (2021)
H.R. Umesh, K.V. Ramesh, K.S. Devaraju, Beni-Suef Univ. J. Basic Appl. Sci. 9, 1 (2020)
V.R. Avupati, R.P. Yejella, A. Akula, G.S. Guntuku, B.R. Doddi, V.R. Vutla, S.R. Anagani, L.S. Adimulam, A.K. Vyricharla, Bioorgan. Med. Chem. Lett. 22, 6442 (2012)
M.R. Ganjali, F. Faridbod, R. Dinarvand, P. Norouzi, S. Riahi, Sensors 8, 1645 (2008)
L. Doadrio, J.M. Sánchez-Montero, J.C. Doadrio, A.J. Salinas, M. Vallet-Regí, Microporous Mesoporous Mater. 195, 43 (2014)
Z. Khodaee, A. Yahyazadeh, N.O. Mahmoodi, J. Heterocycl. Chem. 50, 288 (2013)
N.O. Mahmoodi, J. Parvizi, B. Sharifzadeh, M. Rassa, Arch. Pharm. (Weinheim). 346, 860 (2013)
J. Riedner, P. Vogel, Tetrahedron Asymmetry 15, 2657 (2004)
M.M. Zeydi, O. Mahmoodi, Int. J. Recent Adv. Multidiscip. Res. 3, 2052 (2016)
N.O. Mahmoodi, M.M. Zeydi, J. Iran. Chem. Soc. 15, 311 (2018)
N.O. Mahmoodi, K. Tabatabaeian, H. Kiyani, Helv. Chim. Acta 95(3), 536 (2012)
H. Yazdani Nyaki, N.O. Mahmoodi, M. Pasandideh Nadamani, Can. J. Chem. 99, 482 (2021)
J. Román, A. Castillo, A. Mahn, Molecules 23, 1313 (2018)
K. Rad-Moghadam, N.O. Mahmoodi, F. Asghari-Haji, RSC Adv. 6(33), 27388 (2016)
S. Triloknadh, C. Venkata Rao, K. Nagaraju, N. Hari Krishna, C. Venkata Ramaiah, W. Rajendra, D. Trinath, Y. Suneetha, Bioorgan. Med. Chem. Lett. 28, 1663 (2018)
G. Palareti, C. Legnani, B. Cosmi, E. Antonucci, N. Erba, D. Poli, S. Testa, A. Tosetto, Int. J. Lab. Hematol. 38, 42 (2016)
S.F. Boys, F. Bernardi, Mol. Phys. 19, 553 (1970)
N.O. Mahmoodi, S. Ghodsi, Res. Chem. Intermed. 43, 661 (2017)
R.F.W. Bader, Acc. Chem. Res. 18, 9 (1985)
A. Sheykhi-Estalkhjani, N.O. Mahmoodi, A. Yahyazadeh, M. Pasandideh Nadamani, Res. Chem. Intermed. 46, 3835 (2020)
D. Becke, J. Chem. Phys. 98, 5648 (1993)
N.O. Mahmoodi, F. Ghanbari Pirbasti, Z. Jalalifard, J. Chin. Chem. Soc. 65(4), 383 (2018)
H.Y. Nyaki, N.O. Mahmoodi, Res. Chem. Intermed. 47, 4129 (2021)
N.O. Mahmoodi, B. Khalili, O. Rezaeianzade, A. Ghavidast, Res. Chem. Intermed. 42, 6531 (2016)
L. Zare, N.O. Mahmoodi, A. Yahyazadeh, M. Mamaghani, K. Tabatabaeian, Chin. Chem. Lett. 21(5), 538 (2010)
J. Parvizi, N.O. Mahmoodi, F.G. Pirbasti, M. Rassa, ChemistrySelect 4, 5421 (2019)
Acknowledgements
This probe was supported in part by the Research Committee of the University of Guilan.
Funding
The Research Committee of the University of Guilan.
Author information
Authors and Affiliations
Contributions
NOM, supervised the findings of this work, conceived the presented idea, and edited it. HYN, conceived the presented idea, developed the theory, synthesized all compounds and prepared and revised figures and Tables, and fit them into the Manuscript. HTN, performed the computations of a Molecular Docking Study for Antibacterial Effect and Molecular docking studies for Anticonvulsant Drug Binding (ADB) to the Voltage-Gated Sodium Channel Inner Pore (VGCIP) (docking protein with synthesized compounds). EPK, performed the Antibacterial test and verified the analytical methods.All authors discussed the results and contributed to the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
No competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Yazdani Nyaki, H., Mahmoodi, N.O., Taherpour Nahzomi, H. et al. Two- and three-directional synthesis by 3–7CRs of novel (imidazolidine/thiazolidine)-2,4-diones: preparation, antibacterial, anticonvulsant, and molecular docking investigation. Res Chem Intermed 49, 4149–4175 (2023). https://doi.org/10.1007/s11164-023-05058-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11164-023-05058-8